We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Small Molecule Innate Immune System Stimulators Show Promise as Broad-Spectrum Antiviral Drugs

By LabMedica International staff writers
Posted on 29 Dec 2015
Print article
Image: Structure of the transcription factor IRF3 (interferon regulatory factor 3) (Photo courtesy of Wikimedia Commons).
Image: Structure of the transcription factor IRF3 (interferon regulatory factor 3) (Photo courtesy of Wikimedia Commons).
A family of low molecular weight compounds has been identified that activates the innate immune system to stimulate broad-spectrum protection against viral infections.

The cellular response to virus infection is initiated when pathogen recognition receptors (PRR) engage viral pathogen associated molecular patterns (PAMPs). This process results in induction of downstream signaling pathways that activate the transcription factor IRF3 (interferon regulatory factor 3). IRF3 plays a critical role in antiviral immunity to drive the expression of innate immune response genes, including those encoding antiviral factors, type I interferon, and immune modulatory cytokines that act in concert to restrict virus replication.

Investigators at the University of Washington (Seattle, USA) and their colleagues at the University of Texas Medical Branch (Galveston, USA), and the biotechnology company Kineta Inc. (Seattle, WA, USA) theorized that small molecule agonists that promoted IRF3 activation and induced innate immune gene expression could serve as antivirals to induce tissue-wide innate immunity for effective control of virus infection.

To this end they tested representative compounds and derivatives from a hydroxyquinoline family of small molecules for the ability to suppress infection by a broad range of RNA viruses. They reported in the December 16, 2015, online edition of the Journal of Virology that these molecules could prophylactically or therapeutically control infection in cell culture by pathogenic RNA viruses including West Nile virus, Dengue virus, Hepatitis C virus, influenza A virus, respiratory syncytial virus (RSV), Nipah virus, Lassa virus, and Ebolavirus.

"Our study shows that our compound has an antiviral effect against all these viruses," said senior author Dr. Michael Gale Jr., professor of immunology at the University of Washington.

Knockdown studies mapped this response to the RIG-I-like receptor pathway. RIG-I is a cellular protein known as pathogen recognition receptor. These receptors function to detect viral RNA and signal an innate immune response inside the cell that is essential for limiting and controlling viral infections. This signaling then induces the expression of many innate immune and antiviral genes and the production of antiviral gene products, pro-inflammatory cytokines, chemokines and interferons.

Contributing author Dr. Shawn Iadonato, CSO at Kineta, said, "There is tremendous interest in triggering innate immunity for a number of reasons. One is because some viral infections cannot be treated by traditional antivirals, such as chronic hepatitis B infection. Also, by triggering innate immunity, the viruses will be much less likely to resist the drug actions because they are targeted to the cell through the actions of many different genes and not to the virus itself, thus making drug resistance much harder if not impossible to achieve. It is routine for us to think of broad-spectrum antibiotics, but the equivalent for virology does not exist."

Related Links:

University of Washington
University of Texas Medical Branch
Kineta Inc.


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.